Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/03/24 08:15:01 on US and Canada Markets.
2024-04-03 08:15:01 ET Loop Capital Markets analyst issues BUY recommendation for MBC on April 3, 2024 07:37AM ET. The previous analyst recommendation was Buy. MBC was trading at $18.06 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curr...
MotivHealth and AZOVA Partner to Offer Groundbreaking Birth Doula Support Program PR Newswire ALPINE, Utah , April 3, 2024 /PRNewswire/ -- MotivHealth, a health insurance company defying traditional boundaries, is proud to announce a groundbreaking partnersh...
The Company will deliver a product for defense applications based on its powerful Jupiter Nano platform Rehovot, Israel, April 03, 2024 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a B2B provider of artificial intelli...
The Company will deliver a product for defense applications based on its powerful Jupiter Nano platform Rehovot, Israel, April 03, 2024 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a B2B provider of artificial intelli...
Noventiq Holdings PLC (“Noventiq”), a global digital transformation and cybersecurity solutions and services provider, today announced unaudited key operating highlights for the nine Months ending 12/31/23 including revenues of $340.7 million, an increase of 21.5% in U.S. dollars, a...
Noventiq Holdings PLC (“Noventiq”), a global digital transformation and cybersecurity solutions and services provider, today announced unaudited key operating highlights for the nine Months ending 12/31/23 including revenues of $340.7 million, an increase of 21.5% in U.S. dollars, a...
Success of the brand owed to ongoing pipeline of innovative products designed to delight consumers. Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, celebrates a monumental achievemen...
BOSTON and ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkins...
HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME Trial initiation a step toward potentially treating excessive daytime sleepiness and behavioral symptoms in patients with PWS PR Newswire ...
New research demonstrates value of epigenomic analysis and methylation sequencing with Guardant liquid biopsy portfolio across continuum of cancer care New data show strong performance of Guardant Reveal™ in detection and quantification of residual disease in early-stage breast can...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
-0.96%Change Percent:
SmartFinancial Inc. Company Name:
SMBK Stock Symbol:
NASDAQ Market:
smartfinancialinc.com Website: